Hackensack Meridian Health Oncology Experts
If you are a patient looking for expert cancer care at Hackensack Meridian Health, please visit our cancer care services page to learn about our specialties, find locations, and schedule appointments.
Investigators from Hackensack University Medical Center’s John Theurer Cancer Center (JTCC) — a leading research partner of the NCI-designated Lombardi Comprehensive Cancer Center at Georgetown University, and the best cancer center in New Jersey — presented 65 studies at the 67th American Society of Hematology (ASH) Annual Meeting, held December 6–9, 2025, in Orlando.
Hackensack Meridian Health’s Hennessy Institute for Cancer Prevention & Applied Molecular Medicine is leading a new breast cancer clinical trial called the PINK Study to validate an innovative breath test developed by SpotitEarly. The study will be led by Elias Obeid, M.D., a specialist in breast cancer and cancer genetics, and the medical director of the Hennessy Institute.
Physician-scientists at Hackensack University Medical Center’s John Theurer Cancer Center (JTCC) — a leading research partner of the NCI-designated Lombardi Comprehensive Cancer Center at Georgetown University, and the best Cancer Center in New Jersey — have published three studies advancing medical understanding of the safety and efficacy of CAR-T cell therapy for non-Hodgkin lymphoma, Burkitt lymphoma and large B-cell lymphoma.